153 related articles for article (PubMed ID: 18194867)
1. Hepatitis C virus NS3 protease inhibitors comprising a novel aromatic P1 moiety.
Rönn R; Lampa A; Peterson SD; Gossas T; Akerblom E; Danielson UH; Karlén A; Sandström A
Bioorg Med Chem; 2008 Mar; 16(6):2955-67. PubMed ID: 18194867
[TBL] [Abstract][Full Text] [Related]
2. Discovery of novel potent and selective dipeptide hepatitis C virus NS3/4A serine protease inhibitors.
Raboisson P; Lin TI; Kock Hd; Vendeville S; Vreken WV; McGowan D; Tahri A; Hu L; Lenz O; Delouvroy F; Surleraux D; Wigerinck P; Nilsson M; Rosenquist S; Samuelsson B; Simmen K
Bioorg Med Chem Lett; 2008 Sep; 18(18):5095-100. PubMed ID: 18722116
[TBL] [Abstract][Full Text] [Related]
3. Exploration of acyl sulfonamides as carboxylic acid replacements in protease inhibitors of the hepatitis C virus full-length NS3.
Rönn R; Sabnis YA; Gossas T; Akerblom E; Danielson UH; Hallberg A; Johansson A
Bioorg Med Chem; 2006 Jan; 14(2):544-59. PubMed ID: 16213143
[TBL] [Abstract][Full Text] [Related]
4. Potent inhibitors of the hepatitis C virus NS3 protease: use of a novel P2 cyclopentane-derived template.
Johansson PO; Bäck M; Kvarnström I; Jansson K; Vrang L; Hamelink E; Hallberg A; Rosenquist A; Samuelsson B
Bioorg Med Chem; 2006 Aug; 14(15):5136-51. PubMed ID: 16675222
[TBL] [Abstract][Full Text] [Related]
5. Easy-to-execute carbonylations: microwave synthesis of acyl sulfonamides using Mo(CO)(6) as a solid carbon monoxide source.
Wu X; Rönn R; Gossas T; Larhed M
J Org Chem; 2005 Apr; 70(8):3094-8. PubMed ID: 15822969
[TBL] [Abstract][Full Text] [Related]
6. Discovery of potent sulfonamide P4-capped ketoamide second generation inhibitors of hepatitis C virus NS3 serine protease with favorable pharmacokinetic profiles in preclinical species.
Bogen SL; Arasappan A; Velazquez F; Blackman M; Huelgas R; Pan W; Siegel E; Nair LG; Venkatraman S; Guo Z; Doll R; Shih NY; Njoroge FG
Bioorg Med Chem; 2010 Mar; 18(5):1854-65. PubMed ID: 20149666
[TBL] [Abstract][Full Text] [Related]
7. Novel azapeptide inhibitors of hepatitis C virus serine protease.
Bailey MD; Halmos T; Goudreau N; Lescop E; Llinàs-Brunet M
J Med Chem; 2004 Jul; 47(15):3788-99. PubMed ID: 15239657
[TBL] [Abstract][Full Text] [Related]
8. Molecular modeling based approach, synthesis and in vitro assay to new indole inhibitors of hepatitis C NS3/4A serine protease.
Ismail NS; Hattori M
Bioorg Med Chem; 2011 Jan; 19(1):374-83. PubMed ID: 21138791
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus NS3-4A serine protease inhibitors: SAR of P'2 moiety with improved potency.
Arasappan A; Njoroge FG; Chan TY; Bennett F; Bogen SL; Chen K; Gu H; Hong L; Jao E; Liu YT; Lovey RG; Parekh T; Pike RE; Pinto P; Santhanam B; Venkatraman S; Vaccaro H; Wang H; Yang X; Zhu Z; Mckittrick B; Saksena AK; Girijavallabhan V; Pichardo J; Butkiewicz N; Ingram R; Malcolm B; Prongay A; Yao N; Marten B; Madison V; Kemp S; Levy O; Lim-Wilby M; Tamura S; Ganguly AK
Bioorg Med Chem Lett; 2005 Oct; 15(19):4180-4. PubMed ID: 16087332
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and evaluation of oxygen-containing macrocyclic peptidomimetics as inhibitors of HCV NS3 protease.
Velázquez F; Venkatraman S; Blackman M; Pinto P; Bogen S; Sannigrahi M; Chen K; Pichardo J; Hart A; Tong X; Girijavallabhan V; Njoroge FG
J Med Chem; 2009 Feb; 52(3):700-8. PubMed ID: 19154150
[TBL] [Abstract][Full Text] [Related]
11. Molecular modeling based approach to potent P2-P4 macrocyclic inhibitors of hepatitis C NS3/4A protease.
Liverton NJ; Holloway MK; McCauley JA; Rudd MT; Butcher JW; Carroll SS; DiMuzio J; Fandozzi C; Gilbert KF; Mao SS; McIntyre CJ; Nguyen KT; Romano JJ; Stahlhut M; Wan BL; Olsen DB; Vacca JP
J Am Chem Soc; 2008 Apr; 130(14):4607-9. PubMed ID: 18338894
[TBL] [Abstract][Full Text] [Related]
12. Inhibitors of hepatitis C virus NS3/4A: alpha-ketoamide based macrocyclic inhibitors.
Avolio S; Robertson K; Hernando JI; DiMuzio J; Summa V
Bioorg Med Chem Lett; 2009 Apr; 19(8):2295-8. PubMed ID: 19285390
[TBL] [Abstract][Full Text] [Related]
13. Novel 2-oxoimidazolidine-4-carboxylic acid derivatives as hepatitis C virus NS3-4A serine protease inhibitors: synthesis, activity, and X-ray crystal structure of an enzyme inhibitor complex.
Arasappan A; Njoroge FG; Parekh TN; Yang X; Pichardo J; Butkiewicz N; Prongay A; Yao N; Girijavallabhan V
Bioorg Med Chem Lett; 2004 Dec; 14(23):5751-5. PubMed ID: 15501035
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a diverse set of potential P1 carboxylic acid bioisosteres in hepatitis C virus NS3 protease inhibitors.
Rönn R; Gossas T; Sabnis YA; Daoud H; Kerblom E; Danielson UH; Sandström A
Bioorg Med Chem; 2007 Jun; 15(12):4057-68. PubMed ID: 17449253
[TBL] [Abstract][Full Text] [Related]
15. Phenylglycine as a novel P2 scaffold in hepatitis C virus NS3 protease inhibitors.
Ortqvist P; Peterson SD; Kerblom E; Gossas T; Sabnis YA; Fransson R; Lindeberg G; Helena Danielson U; Karlén A; Sandström A
Bioorg Med Chem; 2007 Feb; 15(3):1448-74. PubMed ID: 17113777
[TBL] [Abstract][Full Text] [Related]
16. Phosphorous acid analogs of novel P2-P4 macrocycles as inhibitors of HCV-NS3 protease.
Pompei M; Francesco ME; Koch U; Liverton NJ; Summa V
Bioorg Med Chem Lett; 2009 May; 19(9):2574-8. PubMed ID: 19328685
[TBL] [Abstract][Full Text] [Related]
17. Resistance profiling of hepatitis C virus protease inhibitors using full-length NS3.
Dahl G; Sandström A; Akerblom E; Danielson UH
Antivir Ther; 2007; 12(5):733-40. PubMed ID: 17713156
[TBL] [Abstract][Full Text] [Related]
18. Discovery of novel phosphonate derivatives as hepatitis C virus NS3 protease inhibitors.
Sheng XC; Pyun HJ; Chaudhary K; Wang J; Doerffler E; Fleury M; McMurtrie D; Chen X; Delaney WE; Kim CU
Bioorg Med Chem Lett; 2009 Jul; 19(13):3453-7. PubMed ID: 19477126
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus NS3-4A serine protease inhibitors: SAR of new P1 derivatives of SCH 503034.
Bogen S; Arasappan A; Pan W; Ruan S; Padilla A; Saksena AK; Girijavallabhan V; Njoroge FG
Bioorg Med Chem Lett; 2008 Jul; 18(14):4219-23. PubMed ID: 18547808
[TBL] [Abstract][Full Text] [Related]
20. Novel potent hepatitis C virus NS3 serine protease inhibitors derived from proline-based macrocycles.
Chen KX; Njoroge FG; Arasappan A; Venkatraman S; Vibulbhan B; Yang W; Parekh TN; Pichardo J; Prongay A; Cheng KC; Butkiewicz N; Yao N; Madison V; Girijavallabhan V
J Med Chem; 2006 Feb; 49(3):995-1005. PubMed ID: 16451065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]